AstraZeneca
United Kingdom
Non-contributor
Company results
$58.7B2025 revenue
$10.2B2025 profit
Cali Fund contributions
$58.7MPotential contribution
$0Contribution made
Company overview
AstraZeneca is a British-Swedish drug maker based in Cambridge, England. It develops medicines for cancer, heart and kidney disease, diabetes, respiratory illness and rare diseases. Many of its treatments are antibodies and other biologics designed using genetic sequences, and its rare disease unit, Alexion, focuses on conditions with genetic causes. It also develops vaccines and antibody treatments built from the genetic code of viruses, and produced one of the first COVID-19 vaccines with the University of Oxford. Genetic data guides how it finds disease targets and tests new treatments.
